UAB Researchers Use CRISPR Technology to Target Childhood Syndrome
In the last couple of years there’s been a bonanza in life sciences around something called CRISPR. This is a process that bacteria do naturally as a defense mechanism, but scientists have figured out how to use it to snip out specific genes from DNA and replace them. In other words, it makes cheaper and more precise genetic editing possible.
“This kind of CRISPR technology that many people are practicing now is going to change the whole field of medicine,” says Tim Townes, director of the UAB Stem Cell Institute.
Townes led a team that published a paper Thursday in Cell Reports on their use of CRISPR to develop a potential new cure for a troubling condition in children. It’s called severe combined immunodeficiency or SCID. Children born with SCID have no immune response so they can’t fight invading viruses or bacteria. It’s more popularly know as the “bubble boy” syndrome. The only current treatment is a bone marrow transplant. Otherwise SCID is fatal.
Townes received skin cells from a patient who was successfully cured through a bone marrow transplant. His team then changed those cells to stem cells and used the CRISPR technique to change the one DNA base pair that causes SCID. The idea is that those cells would then be converted to blood stem cells and transplanted back into the patient, curing him or her.
“So they would be getting their own cells. But those cells would be corrected,” said Townes.
The Food and Drug Administration hasn’t allowed any studies on people using CRISPR yet, but Townes expects UAB to start clinical trials on the SCID therapy within two years.
While CRISPR has the potential to revolutionize biology, from curing genetic diseases to creating mosquitos that can’t carry malaria, it comes with weighty ethical concerns. Scientists and bioethicists are already warning about unintended consequences from changed genes, particularly if they are passed on to children. Also, CRISPR could theoretically be used to by parents to create “designer babies,” genetically engineered for desirable traits.
Scientists in China prompted an uproar earlier this year when they announced they used CRISPR to alter genes in human embryos.
Townes said they check carefully they only change the base pair targeted. He also says they’re only interested in curing disease.
“Any technology can be used for good or not so good purposes,” said Townes. “We want to develop new technology and it’s up to society as a whole to apply them in the correct way.”
Extra: Radiolab explains CRISPR
Light from satellites will ruin majority of some space telescope images, study says
Astronomers have long been concerned about reflections from satellites showing up in images taken by telescopes and other scientific instruments.
Defense Department is reviewing boat strike video for possible release, Hegseth says
In a speech on Saturday, Defense Secretary Pete Hegseth defended the strikes, saying: "President Trump can and will take decisive military action as he sees fit to defend our nation's interests."
Bama, Miami in, Notre Dame out and Indiana No. 1 in College Football Playoff rankings
Nobody paying attention for the past 24 months would be surprised to see Indiana – yes, Indiana – leading the way into this year's College Football Playoff.
McLaren’s Lando Norris wins first F1 title at season-ending Abu Dhabi Grand Prix
Red Bull driver and defending champion Max Verstappen won the race with Norris placing third, which allowed Norris to finish two points ahead of Verstappen in the season-long standings.
A ban on feeding pigeons ruffles lots of feathers in Mumbai
The pigeon population has exploded — a result of people feeding the birds. For some it's a holy duty and a way to connect to nature. Critics point to health risks tied to exposure to pigeon droppings.
UN humanitarian chief: world needs to ‘wake up’ and help stop violence in Sudan
The UN's top humanitarian and emergency relief official has told NPR that the lack of attention from world leaders to the war in Sudan is the "billion dollar question".
